Conference Reports for NATAP

21st Conference on Retroviruses and Opportunistic Infections Boston, MA March 3 - 6, 2014 Back

GSK744 and Rilpivirine as Two Drug Oral Maintenance Therapy: LAI116482 (LATTE) Week 48 Results       Long Acting anTiretroviral Treatment Enabling study (LATTE)   Reported by Jules Levin CROI 2014 March 3-6 Boston, MA   CROI webcast: http://www.croiwebcasts.org/console/player/22172?mediaType=slideVideo&